Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Im Cannabis Corp. (IMCC:NASDAQ), powered by AI.
Im Cannabis Corp. is currently trading at $0.26. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Im Cannabis Corp. on Alpha Lenz.
Im Cannabis Corp.'s P/E ratio is -0.1.
“Im Cannabis Corp. trades at a P/E of -0.1 (undervalued) with modest ROE of -516.3%.”
Ask for details →Im Cannabis Corp. is a globally recognized player in the cannabis industry, specializing in the cultivation, processing, and distribution of medical and recreational cannabis products. With operations particularly focused in Israel, Canada, and Germany, the company leverages its multi-national presence to drive innovation in cannabis research and development. Im Cannabis Corp. plays a pivotal role in advancing cannabis as a viable pharmaceutical alternative, working alongside health professionals to improve patient care. The firm is deeply involved in scientific studies and the development of new strains, aiming to enhance the efficacy and safety of cannabis products. As the industry experiences rapid growth and increasing regulatory acceptance worldwide, Im Cannabis Corp. is positioned at the forefront of this evolution, contributing to the expansion and quality assurance of cannabis offerings across different markets. Its strategic partnerships and comprehensive supply chain management underscore its commitment to leadership in this burgeoning sector.
“Im Cannabis Corp. trades at a P/E of -0.1 (undervalued) with modest ROE of -516.3%.”
Ask for details →Im Cannabis Corp. (ticker: IMCC) is a company listed on NASDAQ in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 95 employees. Market cap is $1M.
The current price is $0.26 with a P/E ratio of -0.1x and P/B of -1.28x.
ROE is -516.26% and operating margin is -21.17%. Annual revenue is $55M.